<code id='449240B9AB'></code><style id='449240B9AB'></style>
    • <acronym id='449240B9AB'></acronym>
      <center id='449240B9AB'><center id='449240B9AB'><tfoot id='449240B9AB'></tfoot></center><abbr id='449240B9AB'><dir id='449240B9AB'><tfoot id='449240B9AB'></tfoot><noframes id='449240B9AB'>

    • <optgroup id='449240B9AB'><strike id='449240B9AB'><sup id='449240B9AB'></sup></strike><code id='449240B9AB'></code></optgroup>
        1. <b id='449240B9AB'><label id='449240B9AB'><select id='449240B9AB'><dt id='449240B9AB'><span id='449240B9AB'></span></dt></select></label></b><u id='449240B9AB'></u>
          <i id='449240B9AB'><strike id='449240B9AB'><tt id='449240B9AB'><pre id='449240B9AB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:3435

          Before he joined Congress, Rep. Raul Ruiz, a Democrat from California, worked in another chaotic environment: the emergency department. Today, he says, he tries to bring his background in medicine and public health to policymaking. In particular, he has turned his attention to a shortage of infectious disease physicians that threatens U.S. preparedness for the next pandemic.

          “As an emergency physician practicing during the H1N1 pandemic, I know how busy the front lines can be, and I know how important infectious disease doctors are to helping us with diagnosis, with decisions, with administrations, with follow-ups, and also reporting to local agencies. And so that’s why I’m so passionate about this issue,” he told me on this week’s episode of the “First Opinion Podcast.”

          advertisement

          We also discussed what it’s like to be a doctor in Congress: “I’m seeing my policy being implemented and its effect in improving the lives of our patients. And that to me is why I’m here,” he said.

          Our conversation was based on his recent First Opinion essay, “The infectious disease doctor shortage threatens future pandemic preparedness.”

          Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

          advertisement

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          With trial win, GSK could get blood cancer drug back on market
          With trial win, GSK could get blood cancer drug back on market

          JUSTINTALLIS/AFPviaGettyImagesLONDON—TheresurrectionofaGSKbloodcancerdrug—whichthecompanywithdrewfro

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          As Taiwan prepares for anti

          FILE-J-10jetfightersperforminformationtocelebratethe60thanniversaryofthePeople'sLiberationArmyAirFor